In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF
Session

Congress : ESC CONGRESS 2017

Topic : Atrial Fibrillation

  • Session type : Satellite Symposium
  • Date : 29 August 2017
  • Time : 12:45 - 13:45
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

5 presentations in this session

Improving patient care with NOACs: where are we now?

Congress : ESC Congress 2017

  • Session : Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

How can NOACs advance care of AF patients undergoing cardioversion?

Congress : ESC Congress 2017

  • Session : Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF
  • Speaker : P Kirchhof (Birmingham,GB)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

NOACs and pulmonary vein ablation: evidence and optimal management.

Congress : ESC Congress 2017

  • Session : Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Detection and prevention: what is the role of NOACs in subclinical AF?

Congress : ESC Congress 2017

  • Session : Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF
  • Speaker : A M W Alings (Breda,NL)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Panel discussion - Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF.

Congress : ESC Congress 2017

  • Session : Leading the way to improved stroke prevention with NOACs: focus on AF patients undergoing non-surgical procedures and on subclinical AF
  • Speaker : H Heidbuchel (Antwerp,BE)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are